VivoSim Labs, Inc.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$7M
↑+81.1% +$3Mvs FY2024
Total Liabilities
$3M
↓-27.6% -$961Kvs FY2024
Equity
$4M
↑+1120.1% +$4Mvs FY2024
Cash
$4M
↑+269.3% +$3Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $7M | $4M |
| Current Assets | $6M | $2M |
| Cash | $4M | $1M |
| ST Investments | $0 | $0 |
| Receivables | $33K | $26K |
| Inventory | $0 | $0 |
| Other Current | $2M | $913K |
| Non-Current Assets | $919K | $2M |
| PPE | $248K | $479K |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $671K | $1M |
| Total Liab+Eq | $7M | $4M |
| Current Liab. | $2M | $3M |
| Accounts Payable | $671K | $930K |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $2M | $2M |
| Non-Current Liab. | $44K | $543K |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $44K | $543K |
| Equity | $4M | $364K |
| Retained Earnings | $350M | $349M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · VIVS · Comparing FY2025 vs FY2024